Testing norepinephrine for blood pressure in septic shock
Part of Infections clinical trials.
This trial studies how norepinephrine affects the heart and circulation in adults with septic shock whose blood pressure stays low after the first day. It may help doctors better choose and adjust medicines to support blood pressure and organ function.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be older than 18 years old.
- You have septic shock, diagnosed at least 24 hours ago.
- Your blood pressure is still low: MAP under 65 mmHg.
- Your care team has decided to increase norepinephrine (NE) because of low blood pressure.
- You are not currently receiving dobutamine.
- You are not pregnant.
- You do not have a “do not resuscitate” decision in place.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether giving a medicine called norepinephrine early and adjusting the dose quickly can help people with sepsis who have very low blood pressure. It is for adults who are diagnosed within the last 3 hours and who have not already received this medicine.
This trial tests different combinations of blood pressure medicines given to patients on a breathing machine who have septic shock. The goal is to find the best dose of a second medicine when norepinephrine alone isn't enough.
This study tests two blood pressure-raising medicines, norepinephrine and angiotensin-II, in people with septic shock. It aims to see which one works better to improve blood flow and oxygen delivery to organs.
This trial examines how the renin-angiotensin-aldosterone system (a hormone system that helps control blood pressure) changes in patients with septic shock, compared to those with sepsis without shock, cardiogenic shock, and healthy volunteers. The goal is to better understand these changes and possibly improve treatment.
This study looks at a new way to guide how safely doctors can reduce the strong blood pressure medicine (norepinephrine) in ICU patients with septic shock. Participants must be on a ventilator and have stable blood pressure and heart function.
This trial studies how blood flow and organ “perfusion” look in ICU patients who are struggling with infection and low blood pressure. It may help doctors better measure and manage shock by comparing hemodynamic readings during standard treatment.
Hear when a new Septic Shock trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.